Learn more about the latest advances from Cedars-Sinai investigators.
Simultaneous bariatric surgery and liver transplant for patients who are severely obese is safe and improves long-term health outcomes, according to a recent Mayo Clinic study. This combined approach offers a needed solution for these patients who are often denied a lifesaving liver transplant due to their weight.
Pesquisadores do Centro de Medicina Personalizada da Mayo Clinic descobriram uma variante gen茅tica rara que pode ser a causa direta da doen莽a hep谩tica esteat贸tica associada 脿 disfun莽茫o metab贸lica.
Investigadores del Centro para Medicina Personalizada en Mayo Clinic han descubierto una variante gen茅tica rara que puede ser la causa directa de la enfermedad hep谩tica esteat贸sica asociada a disfunci贸n metab贸lica, anteriormente conocida como enfermedad del h铆gado graso no alcoh贸lico.
乇賵鬲卮爻鬲乇貙 賵賱丕賷丞 賲賷賳賷爻賵鬲丕 鈥� 丕賰鬲卮賮 亘丕丨孬賵賳 賮賷 賲乇賰夭 賲丕賷賵 賰賱賷賳賰 賱賱胤亘 丕賱賮乇丿賷 賲鬲睾賷乇賸丕 噩賷賳賷賸丕 賳丕丿乇賸丕 賷賲賰賳賴 兀賳 賷爻亘亘 亘卮賰賱 賲亘丕卮乇 賲乇囟 丕賱賰亘丿 丕賱丿賴賳賷 丕賱賲乇鬲亘胤 亘丕賱禺賱賱 丕賱兀賷囟賷貙 賵丕賱匕賷 毓購乇賮 爻丕亘賯賸丕 亘丕爻賲 賲乇囟 丕賱賰亘丿 丕賱丿賴賳賷 睾賷乇 丕賱賰丨賵賱賷.
Researchers from UC San Diego found that children diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD) are at significantly increased risk of premature death and serious long-term health complications. The study, which followed 1,096 children over an average of 8.5 years. Nearly half of all deaths in the cohort were liver-related, and the overall mortality rate was 40 times higher than that of similar peers in the general U.S. population.
Researchers at Mayo Clinic's Center for Individualized Medicine have discovered a rare genetic variant that can directly cause metabolic dysfunction-associated steatotic liver disease, formerly known as nonalcoholic fatty liver disease.
A drug candidate previously successful at treating severe fatty liver disease, reduces atherosclerosis in large mammals, a study suggests. The compound, DT-109, presents as a dual-action drug capable of treating both metabolic dysfunction-associated steatotic liver disease (MASH) and the vascular complications associated with atherosclerosis, a significant advancement in the treatment landscape.
A stress-response protein, CDKN1A, may serve as a biomarker or therapeutic target for MASLD, new research in The FASEB Journal shows. Its expression correlated with disease severity across patient datasets and animal models.
Every eight minutes, someone joins the transplant waiting list in the United States, and just one organ donor can save up to eight lives. Penn State Health experts tell how registering as an organ donor can give others a second chance at life.
Researchers developed liver-targeted immunotherapy (LIT), a novel approach that chemically modifies allergens with mannose sugars, directing them to the liver where immune tolerance develops. In preclinical trials, just two LIT doses provided year-long asthma protection without triggering allergic reactions, outperforming traditional immunotherapy.
Children's Hospital Los Angeles鈥� Liver Transplant Program has the best outcomes for pediatric liver transplants in the country.
Treatment resistance and relapse in the most common type of lung cancer can be traced to a protein called agrin, according to a preclinical study led by Roswell Park. Results of the study, led by Sayan Chakraborty, PhD, Assistant Professor of Oncology at Roswell Park, appear in Advanced Science.
A Johns Hopkins Medicine Organ Transplant Story
he April issue of The American Journal of Gastroenterology highlights new clinical science and reviews, including the gluten-free diet and exposure to arsenic, internet-delivered cognitive behavior therapy for irritable bowel syndrome, a new guideline on gastric premalignant conditions, and multi-society consensus recommendations on bowel preparation.
The Endocrine Society is extremely disappointed the administration has chosen not to finalize a rule that would have made anti-obesity medications more accessible to millions of Americans with obesity.
A new study, led by researchers at the UNC School of Medicine, highlights the latest statistics on gastrointestinal cancers, hospital admissions, liver transplants, and research funding.
Los trasplantes de h铆gado se est谩n convirtiendo en una nueva opci贸n de tratamiento para algunos pacientes con c谩ncer colorrectal cuyos c谩nceres se han diseminado al h铆gado y no son elegibles para otros tipos de cirug铆a. Este enfoque innovador ha tra铆do esperanza a los pacientes con c谩ncer colorrectal que, de otro modo, a menudo enfrentan un pron贸stico sombr铆o.
Os transplantes de f铆gado est茫o se tornando uma nova op莽茫o de tratamento para alguns pacientes com c芒ncer colorretal cujos c芒nceres se espalharam para o f铆gado e n茫o s茫o eleg铆veis para outros tipos de cirurgia. Essa abordagem inovadora tem trazido esperan莽a para pacientes com c芒ncer colorretal que, de outra forma, costumam enfrentar um progn贸stico sombrio.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal 蜜桃传媒 keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
